MEGGLE brings advanced co-processed and DPI excipients to FCE Pharma Brazil


MEGGLE brings advanced co-processed and DPI excipients to FCE Pharma Brazil


Meggle150x88

Press Release | MEGGLE Excipients & Technology

MAY 13, 2019

Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Excipients &Technology (MEGGLE) is returning to Brazil’s major FCE Pharma Expo in São Paulo.

MEGGLE will show an expanded range of lactose-based and co-processed excipients with supporting consultancy services, with emphasis on its latest generation dry powder inhalation (DPI) and co-processed excipients.

Once again, MEGGLE will exhibit in partnership with its Brazilian exclusive distributor, Evonik Brasil from Booth F043 at the São Paulo Expo Center.

Co-processed and DPI excipients

Stars of the MEGGLE display will include the InhaLac® range of sieved, milled and micronized DPI lactose powder excipients and the lactose based coprocessed excipients Cellactose®80, MicroceLac®100, StarLac®, RetaLac®, and CombiLac®.

Video screens on the stand will provide visitors with insights into MEGGLE’s leading product portfolio and global network.

Ideal product choices

Once again, visitors to the stand will be able to use MEGGLE’s web-based Product Configurator that allows direct identification of ideal product by basic applications and characteristics. (See link below).

The MEGGLE team in São Paulo will be led by Fábio Luis Ikuno, Managing Director of MEGGLE Latin America.

“Year after year, FCE Pharma 2019 provides us with a great platform to present our product portfolio to our crowing Latin American customer base, meet our regular customers, explore emerging trends in the industry and networking with existing and potential partners,” Mr. Luis Ikuno commented.

Tangible benefits

“Not only is this one of Latin America’s foremost pharmaceutical networking events but also presents us with a great stage from which to show the advances we’ve made in our leading-edge lactose-based and co-processed products,” he added.

“We can point to tangible cost benefits, performance and process improvements, enhanced efficiencies and productivity, with real scope to re-engineer processes for better products and outcomes,” said Mr. Ikuno.

About MEGGLE Wasserburg

Bavarian-based MEGGLE Wasserburg is one of the world’s experts in lactose-based excipients and powder technology.

From its roots as a dairy operation in the late 1880s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.

MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage form applications, where they can deliver maximum performance.

The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for modified sustained release and controlled release formulations.

About FCE Pharma 2019

The FCE Pharma Expo is an annual event that has become a principal marketing, communications and sales platform for the South and Central American pharmaceutical industry. FCE Pharma is unique in Latin America in bringing the biggest products and services suppliers from across the pharmaceutical industry production chain together under one roof and is a major driver of the pharma-based economy in the region.

Featuring four conference tracks, and a co-located trade exhibition, the 24th FCE Pharma Expo (FCE Brasil 2019) will again be a three-day event opening on May 21 at the São Paulo Expo center in , Brazil.

The 2018 event attracted some 20,000 visitors and 500 exhibitors, representing a host of pharmaceutical industry professionals connected with manufacture, supply and distribution of products and services including packaging, labeling, machines and equipment, quality and contamination control, transport and logistics, outsourcing and consultancy, laboratory and analytical equipment, process equipment, valves, sprays, industrial automation, technology and printing services.

The event is organized by Nürnberg Messe Brazil with more information at http://www.fcepharma.com.br/en/.

Media Contact

Fábio Luis Ikuno, Managing Director, MEGGLE Latin America
Tel: +55 11 2893 4831
Mob: +55 11 99152 0657
Email: fabio.ikuno@meggle.com

OR

Margit Bonnetsmüller, Project Manager Marketing, MEGGLE Excipients &Technology
Tel: +49 8071 73 476
Email: Margit.Bonnetsmueller@meggle.de

Resources

Click on MEGGLE at FCE Pharma 2019 for more information.
Click on MEGGLE to contact the company directly.
Click on Product Configurator to see MEGGLE filtering tool.


Supplier Information
Supplier: MEGGLE Excipients & Technology
Address: Megglestrasse 6-12, 83512 Wasserburg, Germany
Tel: +49 8071 73-476
Fax: +49 8071 73-320
Website: https://www.meggle-pharma.com/


Comments are closed.